Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2023 11 01; 30(11).
View in:
PubMed
subject areas
Bevacizumab
Combined Modality Therapy
Humans
Neoplasms, Second Primary
Neuroendocrine Tumors
Pancreatic Neoplasms
authors with profiles
Hedy Kindler